wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se."/>
公开/公告号US10493071B2
专利类型
公开/公告日2019-12-03
原文格式PDF
申请/专利权人 HELPERBY THERAPEUTICS LIMITED;
申请/专利号US201715608032
发明设计人 PETRA HELGA BECK;MARC BARRY BROWN;DAVID EDWARD CLARK;ANTHONY COATES;HAZEL JOAN DYKE;YANMIN HU;DEREK JOHN LONDESBROUGH;KEITH MILLS;THOMAS DAVID PALLIN;GARY PATRICK REID;GERLINDA STODDART;
申请日2017-05-30
分类号A61K31/4745;A61K31/4439;C07D471/04;A61K31/4709;A61L2;A01N43/90;A61K31/43;A61K31/4706;A61K31/4725;A61K31/496;A61K31/497;A61K31/546;A61K31/7052;
国家 US
入库时间 2022-08-21 11:26:15